Table 3.

Long-term outcome of tumor recurrence in SBRT group and RFA group.

Characteristics	SBRT group (n = 22)	RFA group (n = 38)	P
Local tumor control rate	20 (90.9)	36 (94.7)	.566
Intrahepatic recurrence	10 (45.4)	20 (52.6)	.592
Extrahepatic recurrence	6 (27.2)	0	<.001
Intrahepatic and extrahepatic recurrence	1 (4.5)	1 (2.6)	.665
Time to tumor recurrence (months)	16 (2–33)	14 (1–33)	.934
Treatment of recurrence
Local ablation (RFA)	3 (13.6)	3 (7.9)
TACE	8 (36.3)	1 (2.6)
Systemic treatment	9 (40.9)	0
Radiotherapy	3 (13.6)	0
Supportive care	4 (18.1)	0

Continuous variable is expressed as median (range).

Categorical variable is expressed as number (percentage).

RFA = radiofrequency ablation, SBRT = stereotactic body radiotherapy, TACE = transarterial chemoembolization.